Summary: To demonstrate the usefulness of Long PCR in analyzing gene structures and large deletions we have developed a method to amplify the entire LDL receptor gene, including the promoter region and intron 1. This opens new ways for studies of the gene and allows the detection of certain LDL receptor-specific deletions. For the amplification of the LDL receptor gene, spanning approximately 45.5 Χ 103 bases and divided into 18 exons and 17 introns, we have designed overlapping PCR products (ranging from 4 to 16 Χ 103 bases in length), which can be amplified simultaneously overnight for fast results. It was possible to positively identify two samples from heterozygote carriers of the "5 kB French-Canadian " deletion using this me...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
A number of techniques have been developed as primary screens to scan for DNA sequence variants, inc...
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in...
<p><b>Copyright information:</b></p><p>Taken from "Detection of large deletions in the LDL receptor ...
A variety of rearrangements in the low-density lipoportein receptor (LDLR) gene cause severe forms o...
Summary: The existence of a new Αρα LI restriction fragment length polymorphism in the third intron ...
Attention is currently being paid to the LDL (low density lipoprotein) receptor. It was discovered i...
Familial hypercholesterolemia (FH) is an autosomal semi-dominant disorder caused by defects in the l...
AIMS: To investigate the disease causing event in patients with familial hypercholesterolaemia, carr...
AbstractA cDNA probe for the low density lipoprotein (LDL) receptor gene was used to screen DNA samp...
Polymerase chain reaction (PCR) amplification of specific alleles allowed the rapid detection of a p...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
sequencing of afilnity-captured amplified human DNA: application to the detection of apolipoprotein ...
To investigate the molecular basis of familial hypercholesterolemia (FH) in France, we applied the s...
Geisel J, Weisshaar B, Oette K, Doerfler W. A new Apa LI restriction fragment length polymorphism in...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
A number of techniques have been developed as primary screens to scan for DNA sequence variants, inc...
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in...
<p><b>Copyright information:</b></p><p>Taken from "Detection of large deletions in the LDL receptor ...
A variety of rearrangements in the low-density lipoportein receptor (LDLR) gene cause severe forms o...
Summary: The existence of a new Αρα LI restriction fragment length polymorphism in the third intron ...
Attention is currently being paid to the LDL (low density lipoprotein) receptor. It was discovered i...
Familial hypercholesterolemia (FH) is an autosomal semi-dominant disorder caused by defects in the l...
AIMS: To investigate the disease causing event in patients with familial hypercholesterolaemia, carr...
AbstractA cDNA probe for the low density lipoprotein (LDL) receptor gene was used to screen DNA samp...
Polymerase chain reaction (PCR) amplification of specific alleles allowed the rapid detection of a p...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
sequencing of afilnity-captured amplified human DNA: application to the detection of apolipoprotein ...
To investigate the molecular basis of familial hypercholesterolemia (FH) in France, we applied the s...
Geisel J, Weisshaar B, Oette K, Doerfler W. A new Apa LI restriction fragment length polymorphism in...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
A number of techniques have been developed as primary screens to scan for DNA sequence variants, inc...
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in...